31 years survival rate of ARPE® single-mobility prosthesis in trapeziometacarpal osteoarthritis.
| Autor: | Druel T; Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Cievet-Bonfils M; Institut Chirurgical de la Main et du Membre Supérieur, Villeurbanne, France., Comtet JJ; Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Clinique du Parc, Lyon, France., Gazarian A; Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Clinique du Parc, Lyon, France. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of hand surgery, European volume [J Hand Surg Eur Vol] 2024 Jul; Vol. 49 (7), pp. 914-916. Date of Electronic Publication: 2023 Dec 19. |
| DOI: | 10.1177/17531934231221692 |
| Abstrakt: | A retrospective study of 41 trapeziometacarpal prostheses showed that the implant survival rate decreased linearly over time with a critical period in the first years; ranging from 83% after 5 years to 50% after 30 years. Level of evidence: IV. Competing Interests: Declaration of conflicting interestsThe authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JJC was a consultant for Zimmer Biomet. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|